Press Release: Menarini Silicon Biosystems. : Menarini Silicon Biosystems announces publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH
Results published by the DETECT study group indicate the relevance of assessing biomarker expression in Circulating Tumor Cells (CTCs) with the minimally invasive liquid biopsy-based CELLSEARCH® platform to optimize treatment...
Read full article »
Silicon Biosystems develops, manufactures,and markets instrumentation and consumables for rare-cell sorting, collection, and analysis.
Read more